secwatch.observer — SEC 8-K summary
======================================

Issuer:     MusclePharm Corp (—)
CIK:        0001415684
Form:       8-K
Filed at:   2023-07-19T23:59:59+00:00
Accession:  0001493152-23-024915
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

MusclePharm terminates CFO Gary Shirshac; names Anthony Todaro interim CFO
--------------------------------------------------------------------------

- Gary Shirshac terminated as CFO effective July 10, 2023.
- Anthony Todaro appointed as interim CFO as of same date.
- Company remains in Chapter 11 bankruptcy (filed Dec. 15, 2022, case 22-14422).
- Monthly operating reports from the bankruptcy case attached as exhibits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1415684/000149315223024915/0001493152-23-024915-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1415684/000149315223024915/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-024915

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer